Funding for this research was provided by:
Ministry of Science and ICT, Korea (2021R1A2C1003211)
National Cancer Institute (U01 CA164973, U01 CA164973, R03 CA223890)
National Cancer Institute, US (R03 CA223890)
Received: 3 April 2022
Accepted: 21 October 2022
First Online: 29 November 2022
: The study protocal was approved by the Institutioanl Review Board of the University of Hawaii and the University of Southern California (approval no. CHS9575 and HS-17-00714, respectively). The return of the completed self-administered questionnaire was considered to imply informed consent.
: Not applicable.
: The authors declare that they have no competing interests.